Publicação
Protein-based nanocarriers for targeted drug delivery in type 2 diabetes
| Resumo: | "Type 2 diabetes is a global public health concern, characterized by chronic metabolic dysregulation combining insulin resistance and impaired secretion, leading to disabling and costly complications with a significant impact on life expectancy. In this work, we propose to harness the potential of nanoparticles for biomedical applications, specifically in the development of a targeted drug delivery system.(...)" |
|---|---|
| Autores principais: | Rossana Lopes da Fonseca Santos, Érica |
| Assunto: | Nanoparticles; encapsulins type 2 diabetes mammalian cells pH-sensitive encapsulins; targeted drug delivery |
| Ano: | 2024 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso embargado |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | "Type 2 diabetes is a global public health concern, characterized by chronic metabolic dysregulation combining insulin resistance and impaired secretion, leading to disabling and costly complications with a significant impact on life expectancy. In this work, we propose to harness the potential of nanoparticles for biomedical applications, specifically in the development of a targeted drug delivery system.(...)" |
|---|
Atividades financiadas
Não foram encontrados projetos financiados.